Year in Review: Top Legal Developments of 2023 | Goodwin : v

​​​​​​​As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market. The following is a recap of...

Related Keywords

Delaware , United States , West Virginia , Fiasp Flextouch , Janssen Pharms , Fiasp Penfill , Novolog Penfill , Biocon Biologics , Samsung Bioepis , Richard Andrews , Novolog Flexpen , National Employees Health Plan , Boehringer Ingelheim , Centocor Ortho Biotech Inc , Novartis Pharms Corp , Bristol Myers Squibb , Trustees Of The University Pennsylvania , District Of Delaware Court , Biocon , Amgen , Samsung , Janssen Biotech Inc , Us District Court , Supreme Court , Employer Group Welfare Fund , Welfare Fund Of Plumbers Local Union No , Johnson , Pfizer , Drug Price Negotiation Program , Novo Nordisk Inc , Big Molecule , Suits Against Proposed Biosimilars , Northern District , Commercial Marketing , Inflation Reduction , Inflation Reduction Act , Drug Price Negotiation , Merck Sharp Dohme , Janssen Biotech , Sarepta Therapeutics , Patent Infringement , Gene Therapy , Biologics License Application , Judge Richard Andrews , Delaware District Court , Magistrate Judge Hall , Judge Hall , Judge Andrews , Welfare Fund , Plumbers Local Union , Group Welfare , Plaintiff Motion , Final Approval , Attorney Fees , Service Awards ,